학술논문
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Hematological Malignancies—Myeloablative Effects, Antilymphoma Activity, and Safety Profile
Document Type
Article
Author
Source
In: Clinical Nuclear Medicine . (Clinical Nuclear Medicine, 1 February 2024, 49(2):146-151)
Subject
Language
English
ISSN
15360229
03639762
03639762